Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
Ulagamadesan VenkatesanRuth L ColemanCharles A B ScottShishi XuJaakko TuomilehtoLars RydenRury R Holmannull nullPublished in: Diabetes care (2020)
Acarbose reduced the incidence of diabetes and promoted regression to normoglycemia in Chinese people with IGT and CHD.